(Note: Emphasis in all quotes are ours)
"Mr. A was a 35 year old man who suffered from recurrent depression, seasonal
pattern. No retinal abnormalities were found at two routine ophthalmologic examinations
performed 3 months and 1 week before the start of a 2-week cycle of daily 60 minutes
bright light therapy sessions with full spectrum flourescent light. During treatment
he continued his current medication of clomipramine, 100 mg/day. After 5 days there was
a marked reduction of visual acuity and contrast sensitivity. Results of an Amsler
test revealed a relative central scotoma, and static perimetry showed a marked decrease in
foveal threshold in both eyes. A central yellowish-white lesion with surrounding
orange-red halo was also found in both eyes."
"In conclusion, photic maculopathy in this patient appeared to be related to the association of bright-light therapy, photosensitizing medication and long term exposure to sunlight."